Repligen Corp. (RGEN)
167.93
-2.04
(-1.20%)
USD |
NASDAQ |
Jan 22, 16:00
168.33
+0.40
(+0.24%)
After-Hours: 04:29
Repligen Research and Development Expense (TTM): 51.77M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Enovis Corp. | 112.92M |
| Perspective Therapeutics, Inc. | 61.22M |
| InfuSystem Holdings, Inc. | -- |
| Xtant Medical Holdings, Inc. | 2.165M |
| VolitionRX Ltd. | 9.144M |